Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

400.43

+4.11 (1.04%)

At close: Nov 4, 2026, 4:00 PM EST

395.01

-5.42 (-1.35%)

Pre-market: Nov 5, 2026, 7:47 AM EST

Madrigal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,428	958.4	180.13	-	-	-
Revenue Growth	92.80%	432.05%	-	-	-	-
Cost of Revenue	129.12	56.15	6.23	-	-	-
Gross Profit	1,299	902.26	173.9	-	-	-
Selling, General & Admin	1,064	813.83	435.06	108.15	48.13	37.32
Research & Development	387.89	388.53	236.72	272.35	245.44	205.16
Operating Expenses	1,451	1,202	671.78	380.5	293.57	242.48
Operating Income	-152.65	-300.1	-497.88	-380.5	-293.57	-242.48
Interest Expense	-32.13	-22.31	-14.67	-12.71	-3.96	-
Interest & Investment Income	33.05	37.36	46.65	19.58	2.19	0.36
Other Non Operating Income (Expenses)	-0.46	-0.46	-	-	-	0.27
EBT Excluding Unusual Items	-155.46	-285.51	-465.89	-373.63	-295.35	-241.85
Other Unusual Items	-	-2.78	-	-	-	-
Pretax Income	-155.46	-288.28	-465.89	-373.63	-295.35	-241.85
Net Income	-155.46	-288.28	-465.89	-373.63	-295.35	-241.85
Net Income to Common	-155.46	-288.28	-465.89	-373.63	-295.35	-241.85
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	23	22	21	19	17	17
Shares Outstanding (Diluted)	23	22	21	19	17	17
Shares Change	-13.52%	5.46%	13.83%	9.05%	3.64%	7.05%
EPS (Basic)	-6.73	-12.85	-21.90	-19.99	-17.23	-14.63
EPS (Diluted)	-6.73	-12.85	-21.90	-19.99	-17.23	-14.63
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-168.65	-190.02	-457.03	-325.71	-225.07	-184.13
Free Cash Flow Per Share	-7.31	-8.47	-21.48	-17.43	-13.13	-11.13
Gross Margin	90.96%	94.14%	96.54%	-	-	-
Operating Margin	-10.69%	-31.31%	-276.39%	-	-	-
Profit Margin	-10.89%	-30.08%	-258.64%	-	-	-
Free Cash Flow Margin	-11.81%	-19.83%	-253.72%	-	-	-
EBITDA	-151.1	-298.59	-496.78	-379.97	-293.1	-242.08
EBITDA Margin	-10.58%	-31.16%	-275.78%	-	-	-
D&A For EBITDA	1.55	1.51	1.1	0.53	0.47	0.41
EBIT	-152.65	-300.1	-497.88	-380.5	-293.57	-242.48
EBIT Margin	-10.69%	-31.31%	-276.39%	-	-	-
Advertising Expenses	-	145.1	52.7	-	-	-

SEC Filings: 10-K · 10-Q